• Artemisinin Counters Diabetic Cognitive Decline via NRF2-Dri

  2026-07-07

  Wang et al. (2024) demonstrate that artemisinin improves cognitive function in T2DM mice by suppressing hippocampal neuronal ferroptosis through NRF2 pathway activation. Notably, the use of the NRF2 inhibitor ML385 confirmed the central role of NRF2 in mediating these neuroprotective effects, offering mechanistic clarity and new translational directions for diabetic cognitive impairment research.

• iPSC Platforms Advance Personalized Cystic Fibrosis Drug Tes

  2026-07-06

  Berical et al. introduce a multimodal induced pluripotent stem cell (iPSC) platform for cystic fibrosis research, enabling genotype-specific drug response profiling. This approach enhances understanding of CFTR variant function and supports accelerated development of therapies for rare CFTR mutations.

• Angiotensin II (SKU A1042): Reliable Modeling for Vascular R

  2026-07-06

  This article addresses reproducibility and workflow challenges in hypertension and vascular remodeling studies by leveraging Angiotensin II (SKU A1042) as a validated research tool. By examining real-world scenarios, it demonstrates how evidence-based protocol parameters and high-quality peptide sourcing from APExBIO can enhance sensitivity and reliability in cell and animal models. Cross-referenced literature and protocol insights position Angiotensin II as a cornerstone for advanced cardiovascular investigations.

• SlSLAH1-Mediated Malate Exudation Drives Aluminium Tolerance

  2026-07-05

  This study delineates the regulatory module whereby the SlSTOP1–SlSZP1 transcriptional complex and plasma-membrane-localized SlSLAH1–SlSLAH2 anion channels coordinate malate exudation, conferring aluminium tolerance in tomato. The mechanistic insights advance our understanding of plant adaptation to acidic soils and inform strategies for engineering aluminium-resistant crops.

• 11β-HSD1 Inhibition Attenuates Liver Fibrosis via Notch and

  2026-07-04

  The reference study demonstrates that a novel 11β-HSD1 inhibitor significantly reduces liver fibrosis in a chronic mouse model by suppressing the Notch signaling pathway and increasing natural killer cell-mediated clearance of hepatic stellate cells. These findings reveal a dual immunometabolic mechanism for fibrosis attenuation and provide a foundation for targeted therapies in metabolic dysfunction-associated steatotic liver disease (MASLD).

• Angiotensin II in Vascular Remodeling: Protocols & Innovatio

  2026-07-03

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) empowers precise modeling of hypertension, aortic aneurysm, and macrophage polarization in vascular research. This guide details experimental workflows, troubleshooting, and key insights from recent studies to maximize reproducibility and impact.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-03

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of resolving small proteins and peptides (1–10 kDa) that standard Tris-glycine SDS-PAGE cannot efficiently separate. It is strictly intended for research applications focused on low molecular weight protein and peptide analysis, and should not be used for diagnostic or clinical purposes.

• MCL-1’s Canonical Anti-Apoptotic Role in Breast Cancer Progr

  2026-07-02

  This study demonstrates that breast cancer cells depend on MCL-1 for survival primarily through its canonical anti-apoptotic function. By using genetic and pharmacological inhibition, the research shows that targeting MCL-1 impedes tumor growth only when pro-apoptotic BAX/BAK are present, highlighting apoptosis regulation as the central mechanism and refining therapeutic strategies for breast cancer.

• AP-1 Inhibition Induces Ferroptosis via PI3K/AKT in Myeloma

  2026-07-02

  This study reveals that T-5224, a selective C-Fos/AP-1 inhibitor, induces ferroptotic cell death in multiple myeloma (MM) cells by downregulating the PI3K/AKT pathway. The findings provide mechanistic evidence for targeting AP-1 to engage ferroptosis, offering new directions for MM therapy and potentially enhancing the efficacy of existing treatments.

• BIBP 3226 trifluoroacetate: Reliable Antagonist for NPY/NPFF

  2026-07-01

  This article addresses key experimental challenges in neuropeptide Y (NPY) and neuropeptide FF (NPFF) receptor research, focusing on workflow reproducibility, data interpretation, and product selection. By integrating real laboratory scenarios and recent literature, it demonstrates how BIBP 3226 trifluoroacetate (SKU B7155) from APExBIO provides a validated, high-affinity tool for anxiety, analgesia, and cardiovascular studies.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-07-01

  0.4% Trypan Blue Solution enables rapid, reliable live/dead cell discrimination in cell culture, viability measurement, and cytotoxicity workflows. This reagent is not intended for diagnostic or medical use, and should not be substituted for clinical-grade viability assays or mechanistic apoptosis markers.

• Thiazovivin: ROCK Inhibitor for Stem Cell Survival and Repro

  2026-06-30

  Thiazovivin addresses common workflow bottlenecks in stem cell research by enhancing the efficiency of induced pluripotent stem cell (iPSC) generation and improving human embryonic stem cell (hESC) survival during dissociation. It is best suited for research protocols requiring reliable cell viability and reprogramming efficiency, but should not be used for diagnostic or therapeutic purposes.

• U0126-EtOH: Precision MEK1/2 Inhibition for Neuronal and Leu

  2026-06-30

  Explore how U0126-EtOH, a potent MEK1/2 inhibitor, enables advanced MAPK/ERK pathway studies in neuroprotection and leukemia models. This article uniquely bridges mechanistic insights with assay design, offering practical guidance for translational research.

• Triptolide (PG490): Mechanistic Insights and Translational I

  2026-06-29

  Explore the multifaceted mechanisms of Triptolide (PG490) in cancer and immunology, highlighting recent advances in its application for ovarian cancer cell invasion inhibition and apoptosis induction in T lymphocytes. This article uniquely integrates molecular insights and experimental guidance for optimized research workflows.

• Auranofin: Precision Thioredoxin Reductase Inhibitor in Canc

  2026-06-29

  Auranofin empowers researchers to dissect redox biology and apoptosis with unmatched selectivity, acting as both a thioredoxin reductase inhibitor and a radiosensitizer for tumor cells. This article translates recent mechanistic advances and protocol enhancements into actionable workflows, troubleshooting tips, and advanced applications for oncology and infection biology.

449 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page